Atossa Therapeutics, Inc. (ATOS)
5.83
+0.06
(+1.04%)
USD |
NASDAQ |
Apr 17, 16:00
5.70
-0.13
(-2.23%)
Pre-Market: 08:22
Atossa Therapeutics SG&A Expense (Quarterly) : 5.28M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | 11.94M |
| Plus Therapeutics, Inc. | 4.168M |
| Abeona Therapeutics, Inc. | 18.78M |
| Cell Source, Inc. | 0.3158M |
| Kiora Pharmaceuticals, Inc. | 1.458M |